Additionally, when the level of eight proteins in antibody-based analysis was transformed using PCA, we observed that the control sample with the abnormal concentration (labeled as C4) was clearly deviating from the other samples as well as the AD sample (AD9) with the longer duration of the disease (Fig 6I). Here, C4A is linked to Alzheimer disease.